“Stability of Sulfadiazine Sugar-Free Oral Suspensions for the Treatment of Congenital Toxoplasmosis”. Brazilian Journal of Pharmaceutical Sciences 59 (November 3, 2023). Accessed April 14, 2025. https://journals.usp.br/bjps/article/view/230989.